Faculty Information - Tomohiro Tanikawa

（Last updated : 2024-10-29 09:13:02）

Tomohiro Tanikawa
Department Kawasaki Medical School Kawasaki Medical School, Department of General Internal Medicine 2,

Position Assistant Professor

■ Journal

1.	2024/09/16	Can early precut reduce post-endoscopic retrograde cholangiopancreatography pancreatitis in patients with difficult bile duct cannulation?
2.	2024/04/09	Different Food Preferences in Patients with Gastrointestinal Disorders
3.	2023/09/01	Lean nonalcoholic fatty liver disease: Age-dependent differences in pathology, prognosis, and liver-related events
4.	2023/08/12	Brain activity in response to food images in patients with irritable bowel syndrome and functional dyspepsia
5.	2023/05/10	Soluble CD163 is a predictor of fibrosis and hepatocellular carcinoma development in nonalcoholic steatohepatitis
6.	2022/06/07	Two Cases of Acute Gastric Mucosal Lesions Due to Helicobacter pylori Infection Confirmed to be Transient Infection
7.	2022/05/11	Severe grade of melanosis coli is associated with a higher detection rate of colorectal adenoma
8.	2022/05/05	Asymptomatic gangrenous cholecystitis diagnosed using contrast-enhanced ultrasonography in a patient with pancreatic cancer
9.	2022/04/12	Efficacy of primary drainage by endoscopic ultrasound-guided biliary drainage for unresectable pancreatic adenocarcinoma
10.	2022/03	Afferent-Loop Syndrome Treated with Endoscopic Ultrasound-Guided Drainage of the Afferent Loop with a Plastic Stent
11.	2021/10/18	Increased Colonic Fluorodeoxyglucose Uptake in Melanosis Coli—A Case Series of Three Patients
12.	2021/08/06	Surgical retrieval under general anesthesia of an inadvertent denture ingestion causing cervical esophageal perforation
13.	2021/05/27	Combination of type Ⅳ collagen 7S, albumin concentration, and platelet count predicts prognosis of non-alcoholic fatty liver disease
14.	2021/05/01	Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Cirrhosis Confirmed by Liver Histology after 14 Years.
15.	2021/04/01	Gastric Hyperplastic Polyps after Argon Plasma Coagulation for Gastric Antral Vascular Ectasia in Patients with Liver Cirrhosis-A Case Suggesting the "Gastrin Link Theory".
16.	2021/02/18	Disappearance of Gastric Hyperplastic Polyps after the Discontinuation of Proton Pump Inhibitor in a Patient with Liver Cirrhosis
17.	2021	A Case of Successful Colon Stenting for Abscess due to Gallbladder Colon Fistula Caused by Gallbladder Cancer
18.	2020/09/04	Fatty Liver, and Not Visceral Fat, Is More Associated with Liver Fibrosis and Diabetes in Non-Obese Japanese Individuals:A Cross-Sectional Study
19.	2020	Efficacy and safety of temporary biliary stent for prevention of post-ERCP cholangitis after endoscopic common bile duct stone removal :a retrospective study
20.	2019/10/15	High Prevalence of Autoimmune Gastritis in Patients with Nonalcoholic Steatohepatitis
21.	2017/10	Effective Biomarkers for advance fibrosis NASH and reflect biomarkers as changes of liver fibrosis with NASH
22.	2017/10	Prediction of hepatocellular carcinoma following direct-acting antiviral treatment for chronic hepatitis C
23.	2017/10	Sequential PEG-IFNa-2a and TDF+PEG-IFNa-2a combination therapy after long-term nucleic acid analog treatment effectively reduce hepatitis B surface antigten levels
24.	2016/11	The association with non-alcoholic steatohepatitis and autoimmune gastritis-Coincidence or true nature?
25.	2016/11	The role of Kyoto classification for the diagnosis of Helicobacter pylori infection in young patients
26.	2016/10	Elevated WFAM2BP, ALT flare and HBs decline>1.0Log/ml during Peg IFN were predict drug free and HBs antigen clearance in sequential therapy with Peg-IFN alfa-2a on long-term nucleoside analog treated patients
27.	2016/10	The level of the macrophage activation marker soluble CD163 is apredictor of fibrosis progression and inflammation in non-alcoholic steatohepatitis(NASH)
28.	2016/10	The level of WFA+M2BP levels and alpha-fetoprotein levels are predicted hepatocellular carcinoma after sustained virologic response with chronic hepatitis C patients
29.	2016/06	Herpetic esophagitis following bendamustine-containing regimen
30.	2015	Elevated Serum Levels of M2BPGI Predict the Burned Out NASH and Hepatocellular Carcinoma with Non-Alcoholic Steatohepatitis
Display 5 items
Display all(30)

■ Presentation

1.	2024/06/01	Is precut papillotomy safe for patients under anti-thromboembolic therapy? （口頭）
2.	2024/05/20	Long-term follow study of the esophagogastric junction- a study on the development of short segment barrett esophagus and its extension （ポスター掲示，シンポジウム・ワークショップパネル（その他））
3.	2023/09/07	Lean nonalcoholic steatotic liver disease: Age-dependent differences in pathology, prognosis, and liver-related events （ポスター掲示）
4.	2022/11/05	Characteristics of patients with hepatocellular carcinoma that developed following a diagnosis of nonalcoholic steatohepatitis by liver biopsy （ポスター掲示，シンポジウム・ワークショップパネル（公募））
5.	2018/11/09	Combination of shear-wave elastography and liver fibrosis markers predicts severe fibrosis in patients with non-alcoholic steatohepatitis （ポスター掲示，シンポジウム・ワークショップパネル（公募））
6.	2018/06/02	EVALUATION OF THE PRECUTTING TECHNIQUES FOR DIFFICULT BILIARY CANNULATION TO A MAJOR PAPILLA AROUND A DIVERTICLE （口頭，一般）
7.	2018/06/02	「EVALUATION OF THE PRECUTTING TECHNIQUES FOR DIFFICULT BILIARY CANNULATION TO A MAJOR PAPILLA AROUND A DIVERTICLE」（ポスター掲示，一般）
8.	2017/11/01	METACHRONOUS DEPLOYMENT OF FOUR PLASTIC AND FOUR METALLIC STENTS IN THE PATIENT WITH HILAR BILE DUCT CARCINOMA SUCCESSFULLY ACHIEVED ONLY VIA ENDOSCOPIC PROCEDURE. （口頭，一般）
9.	2017/10/23	Effective Biomarkers for advance fibrosis NASH and reflect biomarkers as changes of liver fibrosis with NASH （ポスター掲示，一般）
10.	2017/10/23	Sequential PEG-IFNa-2a and TDF+PEG-IFNa-2a combination therapy after long-term nucleic acid analog treatment effectively reduce hepatitis B surface antigten levels （ポスター掲示，一般）
11.	2017/10/21	Prediction of hepatocellular carcinoma following direct-acting antiviral treatment for chronic hepatitis C （ポスター掲示，一般）
12.	2017/05/08	Endoscpic findings by Kyoto classification is useful to detect Helicobacter pylori. （ポスター掲示，一般）
13.	2016/11/12	The level of WFA+M2BP levels and alpha-fetoprotein levels are predicted hepatocellular carcinoma after sustained virologic response with chronic hepatitis C patients （口頭，一般）
14.	2016/11/11	Elevated WFAM2BP, ALT flare and HBs decline>1.0Log/ml during Peg IFN were predict drug free and HBs antigen clearance in sequential therapy with Peg-IFN alfa-2a on long-term nucleoside analog treated patients （口頭，一般）
15.	2016/11/11	The level of the macrophage activation marker soluble CD163 is apredictor of fibrosis progression and inflammation in non-alcoholic steatohepatitis(NASH) （口頭，一般）
16.	2016/11/05	The association with non-alcoholic steatohepatitis and autoimmune gastritis-Coincidence or true nature? （口頭）
17.	2016/11/03	The role of Kyoto classification for the diagnosis of Helicobacter pylori infection in young patients （口頭）
18.	2016/08/05	The pancreatic duct stent prevents post-ERCP pancreatitis effectively in the patients with naive papilla （口頭，一般）
19.	2016/05/24	Needle knife precutting papillotomy dose'nt seem to be a risk factor of post ERCP pancreatitis at the selective biliary deep cannulation. （ポスター掲示，一般）
20.	2015/07/03	Elevated serum levels of M2BPGi predict the burned out NASH and Hepatocellular carcinoma with Non-alcoholic steatohepatitis （口頭，一般）
Display 5 items
Display all(20)